Page last updated: 2024-10-31

methylphenidate and Aging

methylphenidate has been researched along with Aging in 89 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
"We hypothesized that a single dose of methylphenidate (MP) would modulate cerebral motor activation and behavior in patients having suffered a subcortical stroke."9.12Methylphenidate modulates cerebral post-stroke reorganization. ( Albucher, JF; Chollet, F; Cognard, C; Conchou, F; Dechaumont-Palacin, S; Franceries, X; Gerdelat, A; Guiraud, V; Leger, A; Loubinoux, I; Marque, P; Pariente, J; Rascol, O; Tardy, J, 2006)
"We hypothesized that a single dose of methylphenidate (MP) would modulate cerebral motor activation and behavior in patients having suffered a subcortical stroke."5.12Methylphenidate modulates cerebral post-stroke reorganization. ( Albucher, JF; Chollet, F; Cognard, C; Conchou, F; Dechaumont-Palacin, S; Franceries, X; Gerdelat, A; Guiraud, V; Leger, A; Loubinoux, I; Marque, P; Pariente, J; Rascol, O; Tardy, J, 2006)
"Many of the neurochemical changes associated with aging brain, particularly lower choline acetyltransferase and higher monoamine oxidase, occur with greater severity in senile dementia, Alzheimer's type (SDAT)."4.76Chemotherapy of cognitive disorders in geriatric subjects. ( Gershon, S; Goodnick, P, 1984)
" Patients receiving methylphenidate in a dosage of 20 mg daily improved significantly over a period of six weeks as measured by results of tests for mental status, ward behavior (nursis' rating), target-symptom response, and physician's and nurses' global evaluations."2.64Withdrawn, apathetic geriatric patients responsive to methylphenidate. ( Kaplitz, SE, 1975)
" To evaluate whether the dose-response relationship follows an inverted-U-shaped curve, MPH effects on cognition are also quantified for low, medium and high doses, respectively."2.50Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies. ( Linssen, AM; Riedel, WJ; Sambeth, A; Vuurman, EF, 2014)
" This dose-response pattern is commonly observed with psychostimulant cognitive modulation."1.46Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents. ( Moghaddam, B; Simon, NW, 2017)
"Methylphenidate (MPH) is a widely prescribed stimulant drug for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents."1.42Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. ( Bouet, V; Boulouard, M; Dauphin, F; Dijkhuizen, RM; Freret, T; Homberg, JR; Klomp, A; Lucassen, PJ; Meerhoff, GF; Reneman, L; van der Marel, K, 2015)
"When methylphenidate was administered after propofol, the mean time to emergence decreased to 6."1.42Ageing delays emergence from general anaesthesia in rats by increasing anaesthetic sensitivity in the brain. ( Brown, EN; Chemali, JJ; Kenny, JD; Kimchi, EY; Olutola, O; Purdon, PL; Solt, K; Taylor, NE, 2015)
"Methylphenidate is a widely prescribed psychostimulant for treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents, which raises questions regarding its potential interference with the developing brain."1.40Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function. ( Dijkhuizen, RM; Homberg, JR; Klomp, A; Lucassen, PJ; Meerhoff, GF; Reneman, L; Schipper, P; van der Marel, K, 2014)
"Methylphenidate (MPH) is a very effective treatment option for children and adolescents with attention-deficit/hyperactivity disorder."1.36Diurnal differences in memory and learning in young and adult rats treated with methylphenidate. ( Comim, CM; Gomes, KM; Inácio, CG; Martins, MR; Quevedo, J; Réus, GZ; Souza, RP; Valvassori, SS, 2010)
"Methylphenidate has been used as an effective treatment for attention deficit hyperactivity disorder (ADHD)."1.35Methylphenidate alters NCS-1 expression in rat brain. ( Barichello, T; Gomes, KM; Gomez, MV; Quevedo, J; Réus, GZ; Romano-Silva, MA; Rosa, DV; Soares, EC; Souza, BR; Souza, RP, 2008)
"Attention deficit hyperactivity disorder is associated with reduced cortical blood flow that is reversible with exposure to the psychostimulant methylphenidate (MPH)."1.35Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors. ( Andersen, SL; Brenhouse, HC; Napierata, L; Sonntag, KC, 2008)
"Methylphenidate is a psychostimulant that acts blocking the dopamine transporter has been used as an effective treatment for Attention Deficit Hyperactivity Disorder."1.35Cerebral DARPP-32 expression after methylphenidate administration in young and adult rats. ( Gomes, KM; Gomez, MV; Inácio, CG; Martins, MR; Quevedo, J; Réus, GZ; Romano-Silva, MA; Rosa, DV; Soares, EC; Souza, BR; Souza, RP; Valvassori, SS, 2009)
"Methylphenidate treatment however did not cause any differences in the number of labelled cells in any group."1.35Effect of postnatal methamphetamine trauma and adolescent methylphenidate treatment on adult hippocampal neurogenesis in gerbils. ( Bagorda, F; Brummelte, S; Schaefers, AT; Teuchert-Noodt, G, 2009)
"Methylphenidate is a central nervous system stimulant used for the treatment of attention-deficit hyperactivity disorder."1.35Methylphenidate treatment increases Na(+), K (+)-ATPase activity in the cerebrum of young and adult rats. ( Comim, CM; Ferreira, AG; Gomes, KM; Matté, C; Mattos, C; Quevedo, J; Scherer, EB; Streck, EL; Wyse, AT, 2009)
"Methylphenidate (MPH) is a psychostimulant drug used to treat attention deficit hyperactivity disorder in children."1.34Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. ( Carrey, N; Chase, T; Soo, E; Wilkinson, M, 2007)
" Thus, our findings have implications for the long-term use of MPH in ADHD."1.33Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum. ( Brown, RE; Carrey, N; Chase, TD; Wilkinson, M, 2005)
" An automated, computerized, open-field activity monitoring system was used to study the dose-response characteristics of acute and repeated MPD administration throughout the 11-day experimental protocol."1.33Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. ( Dafny, N; Swann, AC; Yang, PB, 2006)
"Consequence of the long-term use of psychostimulants as treatment for attention deficit/hyperactivity disorder (ADHD) is unknown, particularly whether treatment with psychostimulants at an early age increases an individual's potential for cross-sensitization to other stimulants exposed at a later age."1.32Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. ( Dafny, N; Swann, AC; Yang, PB, 2003)
"Methylphenidate (MPH) is a stimulant prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD)."1.32Enduring behavioral effects of early exposure to methylphenidate in rats. ( Andersen, SL; Carlezon, WA; Mague, SD, 2003)
"Methylphenidate was used significantly more in the aged group, and modafinil in the younger group."1.31Comparison in symptoms between aged and younger patients with narcolepsy. ( Furuta, H; Temple, HM; Thorpy, MJ, 2001)
"To evaluate attention deficit in Alzheimer's disease (AD) and its relationship to attention deficits associated with aging and with medications altering alertness."1.29Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/antihistaminergic drug and is distinct from deficits in healthy aging. ( Howieson, DB; Kaye, JA; Kishiyama, SS; Oken, BS, 1994)
"Triazolam was effective in treating the phase delay that reappeared after chronotherapy."1.28Daily activity and persistent sleep-wake schedule disorders. ( Iwata, T; Kayukawa, Y; Ohta, T; Okada, T, 1992)
"Muscimol pretreatment (dosages ranging from 0."1.27Ontogeny of GABA-ergic and dopaminergic mediation of gnawing behavior in the mouse. ( Tirelli, E, 1987)
"The dose-response relationships for three stimulants have been explored."1.25The effects of age and illumination on the dose-response curves for three stimulants. ( Isaac, W; Kallman, WM, 1975)
"Methylphenidate was administered s."1.25Methylphenidate effects on avoidance learning at two ages in the rat. ( Gauron, EF; Rowley, VN, 1975)

Research

Studies (89)

TimeframeStudies, this research(%)All Research%
pre-199020 (22.47)18.7374
1990's6 (6.74)18.2507
2000's33 (37.08)29.6817
2010's29 (32.58)24.3611
2020's1 (1.12)2.80

Authors

AuthorsStudies
Weibel, S1
Menard, O1
Ionita, A1
Boumendjel, M1
Cabelguen, C1
Kraemer, C1
Micoulaud-Franchi, JA1
Bioulac, S1
Perroud, N1
Sauvaget, A1
Carton, L1
Gachet, M1
Lopez, R1
Ter Keurst, A1
Tuerlings, JHAM1
Bertholet, EA1
Wijnen, HW1
Grazioli, S1
Mauri, M1
Crippa, A1
Maggioni, E1
Molteni, M1
Brambilla, P1
Nobile, M1
Réus, GZ7
Scaini, G3
Furlanetto, CB2
Morais, MO1
Jeremias, IC1
Mello-Santos, LM1
Freitas, KV1
Quevedo, J9
Streck, EL4
Daniali, S1
Madjd, Z1
Shahbazi, A1
Niknazar, S1
Shahbazzadeh, D1
Gill, KE1
Beveridge, TJ1
Smith, HR1
Porrino, LJ1
van der Marel, K2
Klomp, A2
Meerhoff, GF2
Schipper, P1
Lucassen, PJ2
Homberg, JR2
Dijkhuizen, RM2
Reneman, L2
Linssen, AM1
Sambeth, A1
Vuurman, EF1
Riedel, WJ1
Steiner, H1
Warren, BL1
Van Waes, V1
Bolaños-Guzmán, CA1
Shanks, RA1
Ross, JM1
Doyle, HH1
Helton, AK1
Picou, BN1
Schulz, J1
Tavares, C1
Bryant, S1
Dawson, BL1
Lloyd, SA1
Bouet, V1
Freret, T1
Boulouard, M1
Dauphin, F1
Chemali, JJ1
Kenny, JD1
Olutola, O1
Taylor, NE1
Kimchi, EY1
Purdon, PL1
Brown, EN1
Solt, K1
Titus, SE1
Wessler, LB1
Ferreira, GK1
Gonçalves, CL1
Jeremias, GC1
Somkuwar, SS1
Kantak, KM1
Bardo, MT2
Dwoskin, LP2
Dance, A1
Simon, NW1
Moghaddam, B1
Montagnini, BG1
Silveira, KM1
Pierone, BC1
de Azevedo Camim, N1
Anselmo-Franci, JA1
de Fátima Paccola Mesquita, S1
Kiss, ACI1
Gerardin, DCC1
Souza, RP4
Soares, EC2
Rosa, DV2
Souza, BR2
Barichello, T1
Gomes, KM7
Gomez, MV2
Romano-Silva, MA2
Andersen, SL5
Napierata, L2
Brenhouse, HC2
Sonntag, KC1
Fagundes, AO1
Rezin, GT1
Zugno, AI1
Valvassori, SS4
Inácio, CG4
Martins, MR3
Izquierdo, I1
Bevilaqua, LR1
Rossato, JI1
Lima, RH1
Medina, JH1
Cammarota, M1
Barron, E1
Yang, PB5
Swann, AC5
Dafny, N5
Leo, D1
Adriani, W1
Cavaliere, C1
Cirillo, G1
Marco, EM1
Romano, E1
di Porzio, U1
Papa, M1
Perrone-Capano, C1
Laviola, G1
Kussmaul, L1
Leussis, M1
Zhu, HJ1
Appel, DI1
Jiang, Y1
Markowitz, JS1
Schaefers, AT1
Teuchert-Noodt, G2
Bagorda, F1
Brummelte, S2
Lee, MJ2
Wilcox, VT2
Burau, KD2
Boeck, CR1
Dal-Pizzol, F1
Silveira, PP1
Portella, AK1
Assis, SA1
Nieto, FB1
Diehl, LA1
Crema, LM1
Peres, W1
Costa, G1
Scorza, C1
Quillfeldt, JA1
Lucion, AB1
Dalmaz, C1
Scherer, EB1
Matté, C1
Ferreira, AG1
Comim, CM3
Mattos, C1
Wyse, AT1
Troiano, AR1
Schulzer, M2
de la Fuente-Fernandez, R2
Mak, E2
McKenzie, J2
Sossi, V2
McCormick, S2
Ruth, TJ2
Stoessl, AJ2
Ruocco, LA1
Carnevale, UA1
Treno, C1
Sadile, AG1
Melisi, D1
Arra, C1
Ibba, M1
Schirru, C1
Carboni, E1
Chen, YI1
Choi, JK1
Xu, H1
Ren, J1
Jenkins, BG1
Juárez, J1
Vázquez-Cortés, C1
Biederman, J1
Spencer, TJ1
Monuteaux, MC1
Faraone, SV1
Walker, QD1
Morris, SE1
Arrant, AE1
Nagel, JM1
Parylak, S1
Zhou, G1
Caster, JM1
Kuhn, CM1
Kuramoto, L1
Cragg, J1
Ramachandiran, N1
Au, WL1
Lee, CS1
Calne, DB1
McDougall, SA2
Kozanian, OO1
Greenfield, VY1
Horn, LR1
Gutierrez, A1
Mohd-Yusof, A1
Castellanos, KA1
Avital, A1
Dolev, T1
Aga-Mizrachi, S1
Zubedat, S1
Amos-Kroohs, RM1
Williams, MT1
Vorhees, CV1
DUBE, AH1
OSGOOD, CK1
NOTKIN, H1
FARNER, D1
Carlezon, WA3
Mague, SD1
Brandon, CL1
Marinelli, M1
White, FJ1
Fukui, R1
Svenningsson, P1
Matsuishi, T1
Higashi, H1
Nairn, AC1
Greengard, P1
Nishi, A1
Kilbourn, MR1
Konradi, C1
Chase, TD1
Carrey, N3
Brown, RE2
Wilkinson, M2
Niculescu, M1
Ehrlich, ME1
Unterwald, EM1
Wooters, TE1
Tardy, J1
Pariente, J1
Leger, A1
Dechaumont-Palacin, S1
Gerdelat, A1
Guiraud, V1
Conchou, F1
Albucher, JF1
Marque, P1
Franceries, X1
Cognard, C1
Rascol, O1
Chollet, F1
Loubinoux, I1
Chase, T1
Soo, E1
Grund, T1
Busche, A1
Neddens, J1
Moll, GH1
Dawirs, RR1
Jezierski, G1
Zehle, S1
Bock, J1
Braun, K1
Gruss, M1
Zhu, N1
Weedon, J1
Dow-Edwards, DL1
Vendruscolo, LF1
Izídio, GS1
Takahashi, RN1
Ramos, A1
Goodnick, P1
Gershon, S1
Callaway, E3
Anderson, GM1
Shaywitz, BA1
Leckman, JF1
Hunt, RD1
Shaywitz, SE1
Cohen, DJ1
Gualtieri, CT1
Hicks, RE1
Patrick, K1
Schroeder, SR1
Breese, GR1
Greeley, GH1
Jahnke, G1
Nicholson, GF1
Kizer, JS1
Dickerson, JW1
Pepler, F1
Reigle, TG1
Isaac, WL1
Isaac, W2
Oken, BS1
Kishiyama, SS1
Kaye, JA1
Howieson, DB1
Volkow, ND1
Ding, YS1
Fowler, JS1
Wang, GJ1
Logan, J1
Gatley, SJ1
Hitzemann, R1
Smith, G1
Fields, SD1
Gur, R1
Prendergast, MA1
Jackson, WJ1
Terry, AV1
Kille, NJ1
Arneric, SP1
Decker, MW1
Buccafusco, JJ1
Fang, TY1
Tan, SE1
Collins, RL1
Karper, PE1
Watson, JB1
Crawford, CA1
Furuta, H1
Thorpy, MJ1
Temple, HM1
Arvanitogiannis, A1
Pliakas, AM1
LeBlanc, C1
Penner, MR1
McFadyen, MP1
Pinaud, R1
Robertson, HA1
Bartus, RT1
Eastgate, SM1
Wright, JJ1
Werry, JS1
Glock, D1
Gauron, EF2
Rowley, VN2
Kaplitz, SE1
Kallman, WM1
Ohta, T1
Iwata, T1
Kayukawa, Y1
Okada, T1
Tirelli, E1
Halliday, R1
Naylor, H1
Gratzinger, P1
Prael, R1
Mackay, MC1
Beck, L1
Taylor, R1
Sainz, A1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparing The Effects Of Cognitive Behavioral Therapy And Motor Learning Technique in Adults With Attention Deficit Hyperactivity Disorder.[NCT06064032]36 participants (Anticipated)Interventional2023-10-02Not yet recruiting
Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment: Double Blinded Comparison Between Botulinum Toxin and Baclofen.[NCT02462317]Phase 4184 participants (Actual)Interventional2015-04-30Completed
Dopaminergic Neuromodulation of Decision Making in Young and Middle-Aged Adults[NCT03512171]Phase 165 participants (Actual)Interventional2016-03-31Completed
I123 DAT-SCAN and PET-CT FDG to Assess Brain Function of Parkinson Patients With Different Genetic Characteristic[NCT01089283]80 participants (Anticipated)Observational2010-03-31Not yet recruiting
[NCT01089270]80 participants (Anticipated)Observational2010-03-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

11 reviews available for methylphenidate and Aging

ArticleYear
Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    L'Encephale, 2020, Volume: 46, Issue:1

    Topics: Adult; Aging; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Huma

2020
[Apathetic geriatric patient benefits from methylphenidate].
    Nederlands tijdschrift voor geneeskunde, 2017, Volume: 161

    Topics: Aged; Aged, 80 and over; Aging; Apathy; Dementia; Depression; Female; Humans; Male; Methylphenidate;

2017
Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?
    Journal of affective disorders, 2019, 02-01, Volume: 244

    Topics: Aging; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Biomarkers; Humans;

2019
Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:6

    Topics: Aging; Brain; Central Nervous System Stimulants; Cognition; Dose-Response Relationship, Drug; Health

2014
Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.
    Progress in brain research, 2014, Volume: 211

    Topics: Aging; Animals; Behavior, Animal; Brain; Child; Disease Models, Animal; Fluoxetine; Humans; Methylph

2014
Pharmacologic neuroimaging of the ontogeny of dopamine receptor function.
    Developmental neuroscience, 2010, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Aging; Amphetamine; Animals; Brain; Cerebrovascular Circulation; Cocaine; Dopamin

2010
Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.
    Neuropharmacology, 2004, Volume: 47 Suppl 1

    Topics: Aging; Animals; Behavior; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Chil

2004
Chemotherapy of cognitive disorders in geriatric subjects.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5

    Topics: Adrenocorticotropic Hormone; Aged; Aging; Alzheimer Disease; Arecoline; Brain Chemistry; Choline; Co

1984
Presidential address, 1982. The pharmacology of human information processing.
    Psychophysiology, 1983, Volume: 20, Issue:4

    Topics: Adult; Aged; Aging; Barbiturates; Cognition; Evoked Potentials; Humans; Memory; Methylphenidate; Mid

1983
Developmental and pharmacological aspects of attention deficit disorder (ADD).
    Progress in clinical and biological research, 1983, Volume: 135

    Topics: Aging; Animals; Attention Deficit Disorder with Hyperactivity; Brain Chemistry; Disease Models, Anim

1983
Diet and hyperactivity.
    Journal of human nutrition, 1980, Volume: 34, Issue:3

    Topics: Adolescent; Aging; Amphetamines; Child; Child Behavior Disorders; Child, Preschool; Diet; Dietary Ca

1980

Trials

3 trials available for methylphenidate and Aging

ArticleYear
Age-dependent and age-independent human memory persistence is enhanced by delayed posttraining methylphenidate administration.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Dec-09, Volume: 105, Issue:49

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Central Nervous System Stimulants; Conditioning,

2008
Methylphenidate modulates cerebral post-stroke reorganization.
    NeuroImage, 2006, Nov-15, Volume: 33, Issue:3

    Topics: Aged; Aging; Attention; Behavior; Brain; Central Nervous System Stimulants; Cross-Over Studies; Doub

2006
Withdrawn, apathetic geriatric patients responsive to methylphenidate.
    Journal of the American Geriatrics Society, 1975, Volume: 23, Issue:6

    Topics: Affective Symptoms; Aged; Aging; Clinical Trials as Topic; Female; Geriatric Nursing; Humans; Male;

1975

Other Studies

75 other studies available for methylphenidate and Aging

ArticleYear
Methylphenidate treatment leads to abnormalities on krebs cycle enzymes in the brain of young and adult rats.
    Neurotoxicity research, 2013, Volume: 24, Issue:2

    Topics: Age Factors; Aging; Animals; Brain; Citric Acid Cycle; Methylphenidate; Rats; Rats, Wistar

2013
Chronic Ritalin administration during adulthood increases serotonin pool in rat medial frontal cortex.
    Iranian biomedical journal, 2013, Volume: 17, Issue:3

    Topics: Aging; Animals; Frontal Lobe; Male; Methylphenidate; Rats; Rats, Wistar; Serotonin; Serotonin Plasma

2013
The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats.
    Brain research, 2013, Aug-21, Volume: 1527

    Topics: Aging; Animals; Autoradiography; Behavior, Animal; Brain; Central Nervous System Stimulants; Housing

2013
Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:2

    Topics: Administration, Oral; Aging; Animals; Brain; Central Nervous System Stimulants; Drug Administration

2014
Adolescent exposure to cocaine, amphetamine, and methylphenidate cross-sensitizes adults to methamphetamine with drug- and sex-specific effects.
    Behavioural brain research, 2015, Mar-15, Volume: 281

    Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship,

2015
Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis.
    Neuroscience, 2015, Nov-19, Volume: 309

    Topics: Administration, Oral; Aging; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous

2015
Ageing delays emergence from general anaesthesia in rats by increasing anaesthetic sensitivity in the brain.
    British journal of anaesthesia, 2015, Volume: 115 Suppl 1

    Topics: Aging; Anesthesia, General; Anesthetics; Animals; Brain; Electroencephalography; Isoflurane; Male; M

2015
Methylphenidate increases glucose uptake in the brain of young and adult rats.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:5

    Topics: Aging; Animals; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Glucose;

2015
Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
    Pharmacology, biochemistry, and behavior, 2016, Volume: 141

    Topics: Aging; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Di

2016
Smart drugs: A dose of intelligence.
    Nature, 2016, Mar-03, Volume: 531, Issue:7592

    Topics: Aging; Amphetamines; Animals; Benzhydryl Compounds; Biomedical Enhancement; Caffeine; Child; Cogniti

2016
Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents.
    Brain research, 2017, 01-01, Volume: 1654, Issue:Pt B

    Topics: Aging; Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Psychological

2017
Reproductive parameters of female Wistar rats treated with methylphenidate during development.
    Physiology & behavior, 2016, 12-01, Volume: 167

    Topics: Aging; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Central Nervous System Stimulan

2016
Methylphenidate alters NCS-1 expression in rat brain.
    Neurochemistry international, 2008, Volume: 53, Issue:1-2

    Topics: Aging; Animals; Blotting, Western; Brain Chemistry; Central Nervous System Stimulants; Cerebellum; D

2008
Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors.
    The European journal of neuroscience, 2008, Volume: 27, Issue:11

    Topics: Age Factors; Aging; Animals; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Beha

2008
Methylphenidate increases creatine kinase activity in the brain of young and adult rats.
    Life sciences, 2008, Dec-05, Volume: 83, Issue:23-24

    Topics: Aging; Animals; Brain; Central Nervous System Stimulants; Creatine Kinase; Drug Administration Sched

2008
Cerebral DARPP-32 expression after methylphenidate administration in young and adult rats.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2009, Volume: 27, Issue:1

    Topics: Aging; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimula

2009
Adolescent and adult male spontaneous hyperactive rats (SHR) respond differently to acute and chronic methylphenidate (Ritalin).
    The International journal of neuroscience, 2009, Volume: 119, Issue:1

    Topics: Aging; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Brain Chemis

2009
Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology.
    Genes, brain, and behavior, 2009, Volume: 8, Issue:3

    Topics: Aging; Animals; Behavior, Animal; Cell Enlargement; Cells, Cultured; Central Nervous System Stimulan

2009
Juvenile methylphenidate exposure and factors that influence incentive processing.
    Developmental neuroscience, 2009, Volume: 31, Issue:1-2

    Topics: Administration, Oral; Aging; Animals; Central Nervous System Stimulants; Conditioning, Operant; Fema

2009
Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver.
    Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:9

    Topics: Adolescent; Adult; Aged; Aging; Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Campt

2009
Effect of postnatal methamphetamine trauma and adolescent methylphenidate treatment on adult hippocampal neurogenesis in gerbils.
    European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3

    Topics: Administration, Oral; Aging; Animals; Bromodeoxyuridine; Dentate Gyrus; Gerbillinae; Hippocampus; In

2009
Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats?
    Neuropharmacology, 2009, Volume: 57, Issue:3

    Topics: Aging; Animals; Central Nervous System Stimulants; Circadian Rhythm; Female; Methylphenidate; Motor

2009
Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats.
    Neuroscience letters, 2009, Nov-06, Volume: 465, Issue:1

    Topics: Aging; Analysis of Variance; Animals; Brain; Central Nervous System Stimulants; Cerebellum; Corpus S

2009
Early life experience alters behavioral responses to sweet food and accumbal dopamine metabolism.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2010, Volume: 28, Issue:1

    Topics: Aging; Animals; Animals, Newborn; Conditioning, Classical; Diet; Dopamine; Dopamine Uptake Inhibitor

2010
Methylphenidate treatment increases Na(+), K (+)-ATPase activity in the cerebrum of young and adult rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:12

    Topics: Aging; Animals; Central Nervous System Stimulants; Cerebrum; Corpus Striatum; Dose-Response Relation

2009
Chronic methylphenidate-effects over circadian cycle of young and adult rats submitted to open-field and object recognition tests.
    Current neurovascular research, 2009, Volume: 6, Issue:4

    Topics: Aging; Animals; Central Nervous System Stimulants; Circadian Rhythm; Learning; Male; Memory, Short-T

2009
Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:2

    Topics: Adult; Aged; Aging; Brain; Carbon Radioisotopes; Caudate Nucleus; Dopamine Plasma Membrane Transport

2010
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Behavioural brain research, 2010, Jun-26, Volume: 210, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Aging; Animals; Atomoxetine Hydrochloride; Attention; Attention Defici

2010
Diurnal differences in memory and learning in young and adult rats treated with methylphenidate.
    Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:4

    Topics: Aging; Animals; Avoidance Learning; Injections, Intraperitoneal; Male; Memory; Memory, Short-Term; M

2010
Corticosterone treatment before puberty sensitizes the effect of oral methylphenidate on locomotor activity in preadolescence and produces differential effects in adulthood.
    Brain research, 2010, Jul-30, Volume: 1346

    Topics: Aging; Animals; Central Nervous System Stimulants; Choice Behavior; Corticosterone; Male; Methylphen

2010
A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects.
    The Journal of pediatrics, 2010, Volume: 157, Issue:4

    Topics: Adolescent; Age Factors; Aging; Attention Deficit Disorder with Hyperactivity; Body Height; Body Wei

2010
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: Aging; Amphetamines; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitor

2010
Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:2

    Topics: Aging; Animals; Behavior, Animal; Central Nervous System Stimulants; Circadian Rhythm; Female; Methy

2011
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
    Annals of neurology, 2011, Volume: 69, Issue:5

    Topics: Adult; Aged; Aging; Carbon Isotopes; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucos

2011
One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and D-amphetamine.
    Psychopharmacology, 2011, Volume: 217, Issue:4

    Topics: Aging; Animals; Animals, Suckling; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Dex

2011
Environmental enrichment preceding early adulthood methylphenidate treatment leads to long term increase of corticosterone and testosterone in the rat.
    PloS one, 2011, Volume: 6, Issue:7

    Topics: Aging; Animals; Behavior, Animal; Corticosterone; Environment; Freezing; Locomotion; Male; Methylphe

2011
Neonatal methylphenidate does not impair adult spatial learning in the Morris water maze in rats.
    Neuroscience letters, 2011, Sep-20, Volume: 502, Issue:3

    Topics: Aging; Animals; Animals, Newborn; Central Nervous System Stimulants; Disease Models, Animal; Female;

2011
The effects of an analeptic (ritalin), an ataraxic (reserpine), and a placebo in senile states.
    Journal of chronic diseases, 1957, Volume: 5, Issue:2

    Topics: Aged; Aging; Central Nervous System Stimulants; Disease; Mental Disorders; Methylphenidate; Reserpin

1957
[Studies on the effect of pharmacological agents on animals of different age. IV. The effect of Ritalin and Regitine on young and old rats].
    Gerontologia, 1961, Volume: 5

    Topics: Aging; Animals; Methylphenidate; Phentolamine; Rats; Sympatholytics

1961
Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine.
    Life sciences, 2003, Oct-17, Volume: 73, Issue:22

    Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; In

2003
Enduring behavioral effects of early exposure to methylphenidate in rats.
    Biological psychiatry, 2003, Dec-15, Volume: 54, Issue:12

    Topics: Aging; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Central Nervous System Sti

2003
Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons.
    Biological psychiatry, 2003, Dec-15, Volume: 54, Issue:12

    Topics: Action Potentials; Aging; Analysis of Variance; Animals; Animals, Newborn; Dopamine; Dopamine Agents

2003
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice.
    Journal of neurochemistry, 2003, Volume: 87, Issue:6

    Topics: Aging; Animals; Animals, Newborn; Benzazepines; Cocaine; Dopamine; Dopamine Agonists; Dopamine and c

2003
Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:5

    Topics: Aging; Animals; Brain; Carbon Radioisotopes; Corpus Striatum; Dopamine Plasma Membrane Transport Pro

2004
Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum.
    Brain research. Developmental brain research, 2005, Jun-30, Volume: 157, Issue:2

    Topics: Age Factors; Aging; Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Centra

2005
Age-specific behavioral responses to psychostimulants in mice.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 82, Issue:2

    Topics: Aging; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Male; Met

2005
Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders.
    Psychopharmacology, 2006, Volume: 188, Issue:1

    Topics: Age Factors; Aging; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Rela

2006
Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.
    Brain research bulletin, 2006, Dec-11, Volume: 71, Issue:1-3

    Topics: Adolescent; Age Factors; Aging; Animals; Behavior, Animal; Central Nervous System; Central Nervous S

2006
Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum.
    Neuroscience, 2007, Feb-09, Volume: 144, Issue:3

    Topics: Administration, Oral; Aging; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System Stim

2007
Administration of oral methylphenidate during adolescence prevents suppressive development of dopamine projections into prefrontal cortex and amygdala after an early pharmacological challenge in gerbils.
    Brain research, 2007, Oct-24, Volume: 1176

    Topics: Administration, Oral; Aging; Amygdala; Animals; Attention Deficit Disorder with Hyperactivity; Centr

2007
Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens.
    Journal of neurochemistry, 2007, Volume: 103, Issue:6

    Topics: Aging; Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Dop

2007
Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats.
    Behavioral neuroscience, 2007, Volume: 121, Issue:6

    Topics: Administration, Oral; Age Factors; Aging; Animals; Animals, Newborn; Behavior, Animal; Body Weight;

2007
Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats.
    Behavioural pharmacology, 2008, Volume: 19, Issue:1

    Topics: Age Factors; Aging; Alcohol Drinking; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Cent

2008
Clinical correlates of methylphenidate blood levels.
    Therapeutic drug monitoring, 1984, Volume: 6, Issue:4

    Topics: Adult; Aging; Blood Pressure; Blood Specimen Collection; Child; Emotions; Female; Growth Hormone; Hu

1984
Human information-processing: some effects of methylphenidate, age, and scopolamine.
    Biological psychiatry, 1984, Volume: 19, Issue:5

    Topics: Adult; Aged; Aging; Arousal; Attention; Cognition; Discrimination Learning; Dose-Response Relationsh

1984
Decreased serum 3,5,3'-triiodothyronine and thyroxine levels accompanying acute and chronic ritalin treatment of developing rats.
    Endocrinology, 1980, Volume: 106, Issue:3

    Topics: Aging; Animals; Male; Methylphenidate; Organ Size; Parathyroid Glands; Rats; Thyroid Gland; Thyroide

1980
Behavioral and neurochemical interactions of dextroamphetamine and methylphenidate in rats.
    Journal of pharmaceutical sciences, 1981, Volume: 70, Issue:7

    Topics: Aging; Animals; Behavior, Animal; Brain Chemistry; Catecholamines; Dextroamphetamine; Dose-Response

1981
Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/antihistaminergic drug and is distinct from deficits in healthy aging.
    Neurology, 1994, Volume: 44, Issue:4

    Topics: Aged; Aging; Alzheimer Disease; Analysis of Variance; Attention; Diphenhydramine; Female; Histamine

1994
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Dopamine transporters decrease with age.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Dopamine Plasma

1996
Age-related differences in distractibility and response to methylphenidate in monkeys.
    Cerebral cortex (New York, N.Y. : 1991), 1998, Volume: 8, Issue:2

    Topics: Aging; Animals; Attention; Conditioning, Psychological; Dopamine Agents; Female; Hippocampus; Macaca

1998
The effects of methylphenidate and maturation on exploratory activity in rats.
    The Chinese journal of physiology, 1998, Volume: 41, Issue:1

    Topics: Aging; Animals; Behavior, Animal; Central Nervous System Stimulants; Exploratory Behavior; Male; Met

1998
Effects of repeated methylphenidate treatment in the young rat: sensitization of both locomotor activity and stereotyped sniffing.
    Experimental and clinical psychopharmacology, 1999, Volume: 7, Issue:3

    Topics: Aging; Animals; Decerebrate State; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fem

1999
Comparison in symptoms between aged and younger patients with narcolepsy.
    Psychiatry and clinical neurosciences, 2001, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Aging; Central Nervous System Stimulants; Female; Humans; Male; Methylpheni

2001
Altered responsiveness to cocaine in rats exposed to methylphenidate during development.
    Nature neuroscience, 2002, Volume: 5, Issue:1

    Topics: Adaptation, Physiological; Adult; Aging; Animals; Central Nervous System Stimulants; Child; Cocaine;

2002
Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration.
    Brain research. Developmental brain research, 2002, Apr-30, Volume: 135, Issue:1-2

    Topics: Aging; Animals; Animals, Newborn; Animals, Outbred Strains; Central Nervous System Stimulants; Corpu

2002
Four stimulants of the central nervous system: effects on short-term memory in young versus aged monkeys.
    Journal of the American Geriatrics Society, 1979, Volume: 27, Issue:7

    Topics: Aging; Animals; Caffeine; Central Nervous System Stimulants; Female; Haplorhini; Macaca mulatta; Mal

1979
Behavioural effects of methylphenidate in 6-hydroxydopamine-treated neonatal rats.
    Psychopharmacology, 1978, Jul-06, Volume: 58, Issue:2

    Topics: Aging; Animals; Animals, Newborn; Behavior, Animal; Desipramine; Hydroxydopamines; Methylphenidate;

1978
Effects of methylphenidate on avoidance learning in the aged rat.
    The Journal of general psychology, 1977, Volume: 96, Issue:2d Half

    Topics: Aging; Animals; Avoidance Learning; Conditioning, Operant; Female; Male; Methylphenidate; Motor Acti

1977
The effects of age and illumination on the dose-response curves for three stimulants.
    Psychopharmacologia, 1975, Volume: 40, Issue:4

    Topics: Adaptation, Psychological; Aging; Animals; Arousal; Caffeine; Darkness; Dextroamphetamine; Dose-Resp

1975
Methylphenidate effects on avoidance learning at two ages in the rat.
    European journal of pharmacology, 1975, Volume: 31, Issue:2

    Topics: Aging; Animals; Avoidance Learning; Body Weight; Female; Injections, Subcutaneous; Male; Methylpheni

1975
Daily activity and persistent sleep-wake schedule disorders.
    Progress in neuro-psychopharmacology & biological psychiatry, 1992, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Aging; Amides; Body Temperature; Circadian Rhythm; Female; Humans; Hydroxybutyrat

1992
Ontogeny of GABA-ergic and dopaminergic mediation of gnawing behavior in the mouse.
    Psychopharmacology, 1987, Volume: 92, Issue:1

    Topics: Aging; Animals; Dopamine; Female; gamma-Aminobutyric Acid; Male; Methylphenidate; Mice; Muscimol; St

1987
The effects of stimulant drugs on information processing in elderly adults.
    Journal of gerontology, 1986, Volume: 41, Issue:6

    Topics: Adult; Aged; Aging; Cognition; Dextroamphetamine; Female; Humans; Intelligence; Male; Methylphenidat

1986
Methylphenidate for adolescents with minimal brain dysfunction.
    New York state journal of medicine, 1973, Feb-15, Volume: 73, Issue:4

    Topics: Adolescent; Aging; Attention Deficit Disorder with Hyperactivity; Electroencephalography; Evaluation

1973
Hyperkinetic disease of children: diagnosis and therapy.
    Diseases of the nervous system, 1966, Volume: 7 Suppl, Issue:7

    Topics: Adolescent; Adult; Aging; Brain Damage, Chronic; Child; Chlordiazepoxide; Dextroamphetamine; Humans;

1966